| 查看: 380 | 回复: 1 | ||
yaoguiyang木虫 (小有名气)
|
[求助]
求助构效关系的翻译
|
|
An essential feature of Cyp inhibitors designed to be used as antiviral agents is that the immunosuppressive activity due to CN inhibition is reduced or removed. This has been most effectively achieved by modification of the side chain of the [MeLeu]4 residue, which is involved in a tight ‘aromatic sandwich’ with CN residues Trp352 and Phe356 (Fig. 4). Surprisingly, moving one methyl group at the [MeLeu]4 residue to give [MeIle]4CsA (NIM-811), was found to remove immunosuppressive activity, while retaining the same affinity for CypA as CsA itself.58 This ability to reduce immunosuppressive activity by making small chemical changes at [MeLeu]4 was further demonstrated by [MeVal]4CsA59 and [40-HOMeLeu]4CsA55a,59,60 which show >2500-fold and >100-fold loss of immunosuppressive activity, respectively. The [BMT]1 residue characteristic of the cyclosporins is unique in that in the cyclophilin-bound conformation, this group extends from the cyclophilin binding interface to a region very near the calcineurin-binding region (Figure 2). Early work had suggested that P1-modified cyclosporins can retain cyclophilin binding affinity without maintaining the immunosuppressive activity of 1.73,117 In particular, the Merck group highlighted the cyclophilin binding activity of [CH(OH)CH(CH3)- CH2SCH3]1-CsA, which has 178% of the cyclophilin binding activity of 1 but only 10% of the immunosuppressive potency.74 Aurinia has reported that extension of the BMT group of the cyclosporins and addition of a D-Ala group in the P3 position provides a series of nonimmunosuppressive cyclophilin analogue molecules such as 14 (Figure 9).118 This molecule has more than 14-fold greater inhibition of cyclophilin A isomerase activity relative to 1. Furthermore, while specific assay methodology was not provided, it was asserted that this example has only 3% of the immunosuppressive activity of 1. Although the structure has not been revealed, in July 2013 it was reported that Aurinia had identified a lead candidate and was in the process of fully evaluating the scope of the anti-HCV activity of this analogue. |
回复此楼» 猜你喜欢
面上项目没有好文章就没希望了吗？
已经有15人回复
-
困死了
已经有8人回复
-
不知道还有没有招博士的学校了
已经有5人回复
-
售SCI一区T0P文章，我:8.O.5.5.1.O.5.4,科目齐全,可+急
已经有8人回复
-
材料博士申请
已经有5人回复
-
售SCI一区T0P文章，我:8.O.5.5.1.O.5.4,科目齐全,可+急
已经有7人回复
-
售SCI一区T0P文章，我:8.O.5.5.1.O.5.4,科目齐全,可+急
已经有9人回复
-
还有课题组有博士名额吗
已经有6人回复
-
关于水星近日点进动成因的质疑 与实证分析
已经有10人回复
-
博士申请
已经有3人回复
yaoguiyang
木虫 (小有名气)
 |
2楼2014-11-30 11:06:20